Precision Medicine in Diabetes: Towards Tailored Diagnosis and Therapy
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Personalized Therapy in Clinical Medicine".
Deadline for manuscript submissions: 31 March 2027 | Viewed by 4
Special Issue Editor
2. Institute for Digital Technologies in Medicine & Dentistry, Institut Supérieur der Formation Continue, L-5393 Schuttrange, Luxembourg
3. Department of Biotechnology & Bioinformatics, Technical University Bingen, D-55411 Bingen, Germany
Interests: diabetes mellitus; precision medicine; phenotyping; insulin resistance; cardiovascular risk; adiponectin; hypoglycemia; intact proinsulin; diabetes technology
Special Issue Information
Dear Colleagues,
Diabetes mellitus is not a single disease entity, but rather a heterogeneous group of metabolic disorders characterized by diverse underlying mechanisms, clinical presentations, and trajectories of progression. Despite major therapeutic advances, routine diabetes care still largely relies on generalized diagnostic categories and standardized treatment algorithms, which often fail to reflect individual patients’ biological complexity. Precision medicine has the potential to transform this landscape by integrating biomarkers, genetics, phenotypic characteristics, clinical data, and lifestyle factors to enable more accurate diagnosis, subclassification, risk assessment, and individualized therapy.
This Special Issue, “Precision Medicine in Diabetes: Towards Tailored Diagnosis and Therapy,” is devoted to emerging concepts and evidence that advance a more personalized approach to diabetes care. Topics of interest include, but are not limited to, functional and molecular biomarkers, pathophysiological phenotyping, multi-omics approaches, genetic susceptibility, complication prediction, individualized prevention strategies, and targeted therapeutic interventions. We also welcome submissions on digital medicine, clinical decision-support systems, and artificial intelligence applications that may facilitate the translation of precision diabetology into routine clinical practice.
By bringing together contributions from basic scientists, translational researchers, and clinicians, this Special Issue aims to provide an interdisciplinary perspective on how precision medicine can bridge the gap between mechanistic insight and therapeutic implementation. Ultimately, it seeks to support the development of more tailored, effective, and sustainable strategies for the diagnosis and treatment of diabetes and its complications.
Prof. Dr. Andreas Pfützner
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- precision medicine
- diabetes mellitus
- personalized therapy
- biomarkers
- disease heterogeneity
- genomics
- diabetes complications
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
